SCHEMBL9290602

SCHEMBL9290602

CCN(CC)CCOc1cc(CN(Cc2cc(OCCN(CC)CC)cc(-c3ccccn3)n2)S(=O)(=O)c2ccc(Cl)s2)nc(-c2ccccn2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.36
LYN P07948 1/20 0.36
SRC P12931 1/20 0.36
KMT2A Q03164 4/20 0.35
MAPT P10636 3/20 0.35
LMNA P02545 2/20 0.35
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 2/20 0.35
APAF1 O14727 1/20 0.35
NSD2 O96028 1/20 0.35
TP53 P04637 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35
MAPK1 P28482 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
AGER Q15109 2/20 0.35
ESR1 P03372 3/20 0.33
CHRNA7 P36544 1/20 0.33
HTR6 P50406 3/20 0.33
CYP2D6 P10635 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9290642 0.86 HSP90AA1 (0.40) HTTKMT2AMAPTLMNAMEN1
SCHEMBL8514809 0.86 SQLE (0.42) HTTLYNSRCKMT2AMAPT
SCHEMBL9290644 0.85 HPGD (0.42) HTTLYNSRCKMT2AMAPT
SCHEMBL9290641 0.79 HSP90AA1 (0.40) HTTKMT2AMAPTLMNAMEN1
SCHEMBL17850529 0.76 HSP90AA1 (0.40) KMT2ALMNAKDM4EGAAMAPK1
SCHEMBL9290572 0.76 KDM4E (0.43) HTTLYNSRCKMT2AMAPT
SCHEMBL8515531 0.75 LYN (0.42) HTTLYNSRCKMT2AMAPT
SCHEMBL9290651 0.74 NPY5R (0.44) LYNSRCKMT2AKDM4EMEN1
SCHEMBL9290569 0.72 LYN (0.39) HTTLYNSRCKMT2AMAPT
SCHEMBL17591347 0.71 HSP90AA1 (0.41) KMT2AMAPTLMNAKDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2643299-B1 BIPYRIDINE SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES OR CONDITIONS NOSCIRA SA (ES) 2016-06-22 EP disclosed
US-9284296-B2 Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions AUBERGINE PHARMACEUTICALS LLC (US) 2016-03-15 US disclosed
WO-2012069428-A1 BIPYRIDINE SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES OR CONDITIONS NOSCIRA, S.A. (ES) 2012-05-31 WO disclosed